Dataset Information


Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

ABSTRACT: Hepatocellular carcinoma (HCC), a primary malignancy of the liver, is the second leading cause of cancer mortality worldwide. Fibroblast Growth Factor 19 (FGF19) is one of the most frequently amplified genes in HCC patients. Moreover, mice expressing an FGF19 transgene have been shown to develop HCC. However, the downstream signalling pathways that mediate FGF19-dependent tumorigenesis remain to be deciphered. Here we show that FGF19 triggers a previously unsuspected, non-cell-autonomous program to activate STAT3 signalling in hepatocytes through IL-6 produced in the liver microenvironment. We show that the hepatocyte-specific deletion of Stat3, genetic ablation of Il6, treatment with a neutralizing anti-IL-6 antibody or administration of a small-molecule JAK inhibitor, abolishes FGF19-induced tumorigenesis, while the regulatory functions of FGF19 in bile acid, glucose and energy metabolism remain intact. Collectively, these data reveal a key role for the IL-6/STAT3 axis in potentiating FGF19-driven HCC in mice, a finding which may have translational relevance in HCC pathogenesis.


PROVIDER: S-EPMC5440856 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC5548263 | BioStudies
2012-01-01 | S-EPMC3527604 | BioStudies
2012-01-01 | S-EPMC3477276 | BioStudies
2017-01-01 | S-EPMC5298232 | BioStudies
2018-01-01 | S-EPMC5540823 | BioStudies
2019-01-01 | S-EPMC6399511 | BioStudies
2011-01-01 | S-EPMC3061399 | BioStudies
1000-01-01 | S-EPMC4924662 | BioStudies
2019-01-01 | S-EPMC6627123 | BioStudies
1000-01-01 | S-EPMC5385634 | BioStudies